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ABSTRACT
The adenoviral conjunctivitis is one of the biggest causes of conjunctival infection in the world. 
Conjunctivitis causes relatively nonspecific symptoms, as hyperaemia and chemosis. Even after 
biomicroscopy, complex laboratory tests, such as viral culture, are necessary to identify the pathogen 
or its etiology. To contribute to the better understanding of the pathobiology of the adenoviral 
conjunctivitis, the tear fluids of patients with unilateral acute adenovirus conjunctivitis (UAAC), 
normal donors (control) and patients with allergic conjunctivitis were analyzed. Tear samples were 
collected with Schirmer strips from control, allergic conjunctivitis and UAAC patients, diagnosed by 
clinical signs. UAAC tears were tested positive in viral cultures. After the elution, HA was quantified 
using an ELISA-like fluorometric assay and the protein profile was determined by SDS-PAGE. A profound 
increase in the HA tear content in UAAC patients was found when compared to control and ALC. This 
HA increase in UAAC tears remarkably was not observed in tears from contralateral eyes without 
clinical signs, nor in allergic conjunctivitis. In addition a distinct profile of UAAC tear proteins was 
observed in patients with UAAC. The quantification of HA in the tear fluid is a rapid, sensitive and 
specific test. This molecule might be a biomarker candidate for acute conjunctivitis.
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INTRODUCTION
The adenovirus conjunctivitis is one of the most 
common conjunctival infection. Normally it does not 
result in vision loss, but it frequently causes abstention 
from school or work, with a high economic and social 
cost (Okada and Forrester 2000, Butt and Chodosh 
2006). Although its pathogenesis is not completely 
understood, the role of extracellular matrix compo-
nents has recently been studied (Natividad et al. 2006).
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A healthy ocular surface requires a functional 
tear film. The normal function of tear fluid is due 
to its complex biochemical composition consisting 
of buffered electrolytes and a diversity of proteins 
and glycoconjugates (Van Haeringen 1981, Baker 
et al. 2006).
Hyaluronic acid (HA), an important com-
ponent of the extracellular matrix, is a large 
glycosaminoglycan composed of repeating units of 
β-D-glucuronic acid and N–acetyl-D-glucosamine. 
HA plays an important role in tissue development, 
cell migration, cell proliferation and inflammation 
(Inoue and Katakami 1993, Gomes et al. 2004). 
HA is increased in the tear fluid when corneal 
epithelium erosion is present, and may play an 
important role in corneal epithelium wound healing 
(Oya et al. 1995, Miyauchi et al. 1996). Tear fluid 
consistency (gel-like) can be attributed to HA 
(Itano et al. 1999). Another important characteristic 
of this GAG is its chemical structure that can attract 
ions and water due to a negative charge density 
(Frescura et al. 1994, Yoshida et al. 1996).
Endogenous hyaluronan is present in virtually 
all corneal disorders (Fitzsimmons et al. 1994). HA 
is normally detected only in the corneal endothelium, 
and the presence of any amount of this compound in 
the epithelium or stroma is likely to indicate altered 
tissue (Inoue and Katakami 1993). Vitreous humor 
contains HA and its receptor (CD44), and these 
molecules are also present at the apical surface of 
corneal endothelium (Tengblad 1979).
Tear proteins also play an important role in 
maintaining eye surface integrity and in patients with 
external eye diseases (Avisar et al. 1981, Van Haeringen 
1981, Ballow et al. 1987). The protein fraction of 
normal tears contains antimicrobial factors which 
are important for protecting the external eye from 
infection. These substances are produced by the main 
and accessory lacrimal glands. Important components 
of the hosts defense system for the external eye include 
complement proteins, immunoglobulins, especially 
secretory IgA (sIgA), lysozyme, lipocalin (TSPA) 
and lactoferrin (Friedman 1990, Kuizenga et al. 1991, 
Tragoulias et al. 2005). Lactoferrin, an iron complexing 
protein in normal tears, has bacteriostatic, bactericidal 
and complement (C) inhibitory activity properties 
which make this tear protein an important component 
of the nonspecific host defense system of the external 
eye (Ballow et al. 1987, Flanagan and Willcox 2009). 
Human tear prealbumin, now called tear lipocalin, was 
described as a major protein in tear fluid, and is the 
main lipid binding protein in tears. It exerts important 
functions in eyelid lubrification, and acting as a 
general protection factor for cornea and conjunctiva 
epithelia (Redl 2000). IgA is the only significant 
immunoglobulin found in tear film. The antibodies are 
postulated to play a role in preventing adherence of 
microorganisms to the ocular surface (Alizadeh et al. 
2001, Knop and Knop 2005). Another component of 
tears is lysozyme, a bacteriolytic protein first described 
by Fleming (Fleming 1922, McClellan 1997, Caffery 
et al. 2008). An allergen exposure can cause a marked 
increase in lysozyme secretion (Proud et al. 1998).
The aim of this study was to quantify HA 
content and verify the protein profile of tear fluids 
from patients with adenoviral conjunctivitis and 
compare them with normal donors.
MATERIALS AND METHODS
SUBJECTS
Tear samples were obtained from 53 patients; 
15 eyes affected by acute adenoviral conjunctivitis, 
diagnosed from clinical signs, without epithelial 
defects and testing positive for viral culture and 15 
contralateral eyes without clinical signs; as well as 
both eyes from 23 normal subjects as controls (total 
46 control eyes). Tears from 15 patients affected by 
allergic conjunctivitis (total 26 allergic conjunctivitis 
eyes) were also analyzed. Patients with systemic 
diseases (rheumatoid arthritis, liver diseases and 
cancer) that could alter the concentration of secreted 
HA were excluded from the study. The characteristics 
of the subjects are shown in Table I. The patients with 
unilateral acute adenovirus conjunctivitis (UAAC) 
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presented all of the following signs and symptoms: 
conjunctival hyperemia, ocular secretion, no corneal 
epithelium erosion, conjunctival follicular reaction, 
no use of any ocular medication and symptoms that 
had started for no more than 3 days prior. In the 
contralateral eye group, we included contralateral 
eyes from patients with UAAC that didn’t have any 
clinical signs of acute conjunctivitis. Diagnosis of 
allergic conjunctivitis was based on clinical history 
and evaluation of signs and symptoms. Patients 
included in the study were in an active inflammatory 
phase of the disease with active limbal infiltrates 
and were free of topical antihistamines and mast cell 
stabilizers for at least 3 days, topical corticosteroids 
for at least 7 days, and systemic antiallergic treatment 
for at least 2 week at the time of first presentations. 
The control group constituted of patients without 
any ocular or systemic diseases.
The ethics Committee of the Federal University 
of São Paulo approved this protocol and a written 
informed consent was obtained from each subject. 
The study protocol adhered to the tenets of The 
Declaration of Helsinki.
SAMPLE COLLECTION
For collecting the tears, Schirmer strips were placed in 
the temporal side of each eye under the eyelid, during 
5 minutes, without any use of topical anesthetics. 
The strips were dried at room temperature and stored 
at –20°C until analysis. The same procedure was 
performed for the three groups.
ADENOVIRAL CULTURE
At the same time, conjunctival swabs were collected 
in the affected eye group in medium appropriate for 
adenoviral culture, using Hep-2 cells as described 
by de Paiva et al. 1992.
TEAR SAMPLE PREPARATION
Tear compounds were eluted from the Schirmer 
strips using 100 µL of distilled water, and HA and 
protein content analyses were performed.
HA MEASUREMENT
HA content in tear fluids was assayed by a non-
competitive and non-isotopic fluoroassay (Martins 
et al. 2003). Eluted tear fluids and standard 
concentrations of HA (Sigma, St. Louis, MO) 
were added to 96 multiwell plates (FluoroNUNC 
Maxisorp-microtiterplates, Roskilde, Denmark) 
previously coated with HA-binding protein. The 
plates were then sequencially incubated with 
biotinylated HA-binding protein and europium-
labeled streptavidin (Amershan, Piscataway, NJ). 
Afterwards, the europium remaining in the solid 
phase was released by an enhancement solution and 
the fluorescence was measured using a time-resolved 
fluorometer (Perkin–Elmer Life Sciences-Wallac Oy, 
Turku, Finland). The data (counts/s) were processed 
automatically using the MultiCalc software program 
(Perkin-Elmer Life Sciences-Wallac Oy) and values 
are expressed as ng/mg protein.
PROTEIN ANALYSIS
Total tear protein concentration was determined 
using a colorimetric assay kit according to the 
manufacturer’s instructions (Protein Assay Kit 
from Bio-Rad, Hercules, CA). The protein profile 
was analyzed through sodium dodecylsulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) 
as previously described (Laemmli 1970). Briefly, 
10 µg of protein from the tear samples were applied 
to a 3-20% linear gradient polyacrylamide gel 
under reducing conditions. After electrophoresis, 
Patients 
UAAC
Patients 
ALC
Donors 
(both eyes)
No. 15 15 23
Age (mean ± SD) 32.6 ± 14.7 11.8 ± 3.72 25.2 ± 3.02
Sex
F 9 4 15
M 6 11 8
TABLE I
Patients and donors characteristics.
UAAC, unilateral acute adenovirus conjunctivitis; ALC, 
allergic conjunctivitis; F, female; M, male. Table shows 
standard errors for patients age.
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the gels were stained by comassie blue (Bio-Rad, 
Hercules, CA). Each protein band was quantified 
by densitometry using the software ImageJ Version 
10.2 for Mac (U.S. National Institutes of Health, 
Bethesda, Maryland, USA). The results are 
expressed by arbitrary densitometric units (ADU).
STATISTICAL ANALYSIS
Data are expressed as mean ± standard error of the 
mean. Statistical analyses were performed using 
One-way ANOVA with Bonferroni´s Multiple 
Comparison test, using Graph Pad Prism 5.0 
software for Mac. A 95% confidence interval and 
a 5% level of significance were adopted; therefore, 
results with P-value less than or equal to 0.05 were 
considered significant.
RESULTS
COMPARISON OF HYALURONIC ACID CONTENT IN TEAR FLUID 
FROM PATIENTS AFFECTED BY CONJUNCTIVITIS AND NORMAL 
DONORS
The HA content in tears from eyes with UAAC 
(n=15), from contralateral eyes (n=15), from 
eyes of normal donors (n=46) and from allergic 
conjunctivitis (n=26) was: 102.9 ± 19.9 ng/
mg protein; 51.02 ± 8.5 ng/mg protein, 25.2 ± 
2.3 ng/mg protein and 35.5 ± 4.5 ng/mg protein, 
respectively. The comparison of HA content among 
the three groups showed a significant difference 
(P< 0.0001) (Fig. 1). UAAC tears presented higher 
HA concentrations when compared to either normal 
tears (P< 0.0001), tears from contralateral eyes or 
tears from allergic conjunctivitis. HA content in 
tears from contralateral eyes did not differ (P> 0.05) 
from tears from normal donors or from tears from 
patients affected by allergic conjunctivitis.
PROTEIN CONTENT AND QUALITATIVE ANALYSIS OF TEARS
The protein analysis showed distinct protein 
profiles when comparing tears from UAAC eyes 
to tears from contralateral eyes. Polypeptide 
bands were identified by matching their migrations 
to those of molecular weight standards. Tear protein 
patterns from normal donors have been exhaustively 
reported by previous investigators (Ballow et al. 
1987, Lopez-Cisternas et al. 2006, Mann and Tighe 
2007) and are represented by lactoferrin (79 kDa), 
sIgA-heavy chain (66 kDa), sIgA-light chain 
(27 kDa), lipocalin (TSPA, 18 kDa), and lysozyme 
(14 kDa) (Fig. 2). Figure 3 shows that eyes affected 
by UAAC presented higher amounts of sIgA-heavy 
chain when compared to the contralateral eyes 
(CLE) or allergic conjunctivitis (ALC) (P=0.0368). 
On the other hand, UAAC presented lower 
quantities of lipocalin or TSPA (P=0.0394) and 
lactoferrin (P=0.0018) when compared to CLE. 
No differences were found in the protein content 
of sIgA-light chain among UAAC, CLE and ALC. 
Finally, lysozyme is increased in tears from ALC 
compared to UAAC or CLE (P<0.0001).
DISCUSSION
We show that UAAC leads to a significant increase 
in tear HA content. The difference found between 
Figure 1 - Hyaluronic acid content in tear fluid of UAAC 
patients, normal donors and allergic conjunctivitis. HA was 
measured in tears by a non-competitive fluorometric ELISA-
like assay. The HA content in tears of all UAAC eyes, in the 
contralateral eyes (CLE), in eyes of normal donors (CTR) and 
allergic conjunctivitis (ALC) was 102.9 ± 19.9 ng/mg protein; 
51.02 ± 8.5 ng/mg protein; 25.2 ± 2.3 ng/mg protein and 
35.5 ± 4.5 ng/mg protein respectively. The statistical analysis 
was performed using ANOVA followed by Bonferroni's 
post test. Abbreviations: UAAC, unilateral acute adenoviral 
conjunctivitis; CLE, contralateral non-affected eye; ALC, 
Allergic conjunctivitis.
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HA tear content in UAAC was 2 times greater than 
that from contralateral eyes without clinical signs and 
4 times higher than in the tears from normal donors 
indicating that HA could be a marker for subclinical 
inflammation. HA levels in tears of patients affected 
by allergic conjunctivitis showed no differences 
compared to tears from normal subjects.
Our results show that the levels of HA content 
in the tear fluid are related to the viral injury and 
conjuctival inflammation, suggesting that higher 
levels lead to a situation in which the viscoelastic 
properties of HA may protect corneal epithelium 
and help promote wound healing (Laurent and 
Fraser 1992, Miyauchi et al. 1996).
We may also consider that HA may be playing 
an important role in promoting inflammatory cell 
migration to the conjunctiva, possibly modulating 
inflammatory cytokine release (Mummert 2005).
UAAC, CLE and ALC tear protein profiles 
showed 79, 66, 27, 24, 18, and 14 kDa bands, which 
were a constant feature with different amounts 
of each protein (Fig. 2). The protein profile of 
tears is well established in normal eye (Kuizenga 
et al. 1991). In accordance to the data reported 
by other authors (Janssen and Van Bijsterveld 
1981, Kuizenga et al. 1991), we propose that the 
proteins observed in the present study correspond 
to lactoferrin (79 kDa), sIgA-heavy chain (66 kDa), 
sIgA-light chain (27 kDa), lipocalin (TSPA, 18 kDa), 
and lysozyme (14 kDa), respectively.
A higher content of sIgA was found in UAAC, 
when compared to CLE. Secretory IgA-enriched 
fluid presumably augments the effectiveness of 
the external barrier to microbial adherence and 
increases the efficiency by which pathogens 
are processed by the immune and inflammatory 
systems (Sack et al. 1992). No differences were 
found in sIgA light chain content.
The decrease in lactoferrin and lipocalin levels 
in UAAC tears may occur evoked by major reflex 
tearing caused by inflammation (de Paiva et al. 
1992). Furthermore, lactoferrin has been shown to 
Figure 2 - Protein profile in tear of allergic and adenoviral conjunctivitis. Electrophoretic profiles of 
human tear fluid on SDS-PAGE revealed by Coomassie blue staining. In A (contralateral eye), B (acute 
adenoviral conjunctivitis eye) and C (allergic conjunctivitis), the corresponding profiles of 4 different 
subjects are shown. Protein bands were identified by matching their migrations to those of molecular 
weight standards; lactoferrin (79 kDa), serum albumin and sIgA-heavy chain (66 kDa), sIgA-light chain 
(27 kDa), lipocalin (TPSA, 18 kDa), and lysozyme (14 kDa).
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possess antiviral activity against adenovirus. This 
possible down regulation may be an evolutionary 
mechanism used by adenovirus to survive in ocular 
tissue. There was no difference between UAAC 
and CLE regarding lysozyme secretion, but it was 
increased in ALC tears, since an allergen exposure 
can cause a marked increase in lysozyme secretion 
(Proud et al. 1998).
CONCLUSIONS
In this study we were able to identify an important 
increase in HA tear content in patients affected by 
UAAC, compared with normal donors or allergic 
conjunctivitis, using a rapid and non invasive 
method. Regarding protein analysis we could verify 
a distinct protein profile in tear fluid of UAAC 
patients. Taken together these results indicate that 
the increase in HA content seems to play a role in 
the tear fluid of UAAC patients. The quantification 
of HA in the tear fluid is a rapid, sensitive and 
specific test. This molecule might be a biomarker 
candidate for acute conjunctivitis.
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ABBREVIATIONS:
UAAC, unilateral acute adenovirus conjunctivitis; 
CLE, contralateral non-affected eye; ALC, allergic 
Figure 3 - Protein quantification in tear of allergic and adenoviral conjunctivitis. Protein bands of human tear fluid on SDS-PAGE 
were quantified by densitometry: lactoferrin (79 kDa), serum albumin and sIgA-heavy chain (66 kDa), sIgA-light chain (27 kDa), 
lipocalin (TPSA, 18 kDa), and lysozyme (14 kDa). The results are expressed by arbitrary densitometric units (ADU). Statistical 
analyses were performed by one way ANOVA and Bonferroni's post test. Abbreviations: CLE, contralateral non-affected eye; 
UAAC, unilateral acute adenoviral conjunctivitis eye; ALC, allergic conjunctivitis.
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conjunctivitis; HA, hyaluronic acid; GAG, glyo-
saminoglycan; SDS-PAGE, sodium dodecylsulfate 
polyacrylamide gel electrophoresis.
RESUMO
A conjuntivite causada por adenovírus é uma das maiores 
causas de infecção da conjuntiva no mundo. A conjuntivite 
provoca sintomas relativamente inespecíficos, como 
hiperemia e quemose. Mesmo depois de biomicroscopia, 
testes laboratoriais complexos, como cultura viral, 
são necessários para identificar o patógeno ou sua 
etiologia. Para contribuir para o melhor entendimento 
da fisiopatologia da conjuntivite causada por adenovírus, 
lágrimas de pacientes com conjuntivite aguda unilateral 
causada por adenovírus (UAAC), de doadores normais 
(controle) e de pacientes com conjuntivite alérgica foram 
analisadas. As amostras foram coletadas com tiras de 
Schirmer de doadores normais, pacientes com conjuntivite 
alérgica e pacientes com UAAC diagnosticados por sinais 
clínicos e testes positivos em culturas virais. Após a 
eluição das lágrimas, o HA foi quantificado utilizando um 
ensaio fluorométrico semelhante ao ELISA e o perfil da 
proteína foi determinado por SDS-PAGE. Um aumento 
profundo no conteúdo de HA em lágrima de pacientes 
com UAAC foi encontrado quando comparado com o 
controle ou a conjuntivite alérgica. Este aumento de HA 
em lágrimas de pacientes com UAAC não foi observado 
em lágrimas do olho contralateral sem sinais clínicos 
ou de pacientes com conjuntivite alérgica. Além disso 
observou-se um perfil distinto de proteínas nas lágrimas 
de pacientes com UAAC. A quantificação de HA no 
fluido lacrimal é um ensaio rápido, sensível e específico. 
Esta molécula pode ser um bom candidato a biomarcador 
para conjuntivite aguda.
Palavras-chave: conjuntivite, glicosaminoglicanos, ácido 
hialurônico, lágrima.
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